Why humans should not eat broom straws: Pericarditis and endocarditis

por Novotny, William Edward, Keel, Cynthia P
Publicado 2020

The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new‐onset type 1 diabetes

por Novotny, William E., Fiordalisi, Irma, Keel, Cynthia P., Harris, Glenn D.
Publicado 2021

Effect of rifampin and itraconazole on the pharmacokinetics of zanubrutinib (a Bruton's tyrosine kinase inhibitor) in Asian and non-Asian healthy subjects

por Mu, Song, Tang, Zhiyu, Novotny, William, Tawashi, Manal, Li, Ta-Kai, Ou, Ying, Sahasranaman, Srikumar
Publicado 2019

Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P‐gp and BCRP

por Ou, Ying C., Tang, Zhiyu, Novotny, William, Tawashi, Manal, Li, Ta‐Kai, Coleman, Hugh A., Sahasranaman, Srikumar
Publicado 2021

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia

por Tam, Constantine S., Trotman, Judith, Opat, Stephen, Stern, Jennifer C., Allewelt, Heather, By, Kunthel, Novotny, William, Huang, Jane, Tedeschi, Alessandra
Publicado 2023

No QTc Prolongation With Zanubrutinib: Results of Concentration‐QTc Analysis From a Thorough QT Study in Healthy Subjects

por Mu, Song, Darpo, Borje, Tang, Zhiyu, Novotny, William, Tawashi, Manal, Xue, Hongqi, Willett, Michael, Lin, Leo, Sahasranaman, Sri, Ou, Ying C.
Publicado 2020

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma

por Phillips, Tycel, Chan, Henry, Tam, Constantine S., Tedeschi, Alessandra, Johnston, Patrick, Oh, Sung Yong, Opat, Stephen, Eom, Hyeon-Seok, Allewelt, Heather, Stern, Jennifer C., Tan, Ziwen, Novotny, William, Huang, Jane, Trotman, Judith
Publicado 2022

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

por Xu, Wei, Yang, Shenmiao, Zhou, Keshu, Pan, Ling, Li, Zengjun, Zhou, Jianfeng, Gao, Sujun, Zhou, Daobin, Hu, Jianda, Feng, Ru, Huang, Haiwen, Ji, Meng, Guo, Haiyi, Huang, Jane, Novotny, William, Feng, Shibao, Li, Jianyong
Publicado 2020

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma

por Yang, Haiyan, Xiang, Bing, Song, Yuqin, Zhang, Huilai, Zhao, Weili, Zou, Dehui, Lv, Fangfang, Guo, Wei, Liu, Aichun, Li, Caixia, Tan, Ziwen, Liu, Yang, Fu, Lina, Guo, Haiyi, Novotny, William, Huang, Jane, Li, Yufu
Publicado 2022

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study

por Cull, Gavin, Burger, Jan A., Opat, Stephen, Gottlieb, David, Verner, Emma, Trotman, Judith, Marlton, Paula, Munoz, Javier, Johnston, Patrick, Simpson, David, Stern, Jennifer C., Prathikanti, Radha, Wu, Kenneth, Novotny, William, Huang, Jane, Tam, Constantine S.
Publicado 2021

Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study

por Song, Yuqin, Gao, Quanli, Zhang, Huilai, Fan, Lei, Zhou, Jianfeng, Zou, Dehui, Li, Wei, Yang, Haiyan, Liu, Ting, Wang, Quanshun, Lv, Fangfang, Guo, Haiyi, Yang, Liudi, Elstrom, Rebecca, Huang, Jane, Novotny, William, Wei, Vivian, Zhu, Jun
Publicado 2019

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

por Song, Yuqin, Zhou, Keshu, Zou, Dehui, Zhou, Jianfeng, Hu, Jianda, Yang, Haiyan, Zhang, Huilai, Ji, Jie, Xu, Wei, Jin, Jie, Lv, Fangfang, Feng, Ru, Gao, Sujun, Guo, Haiyi, Zhou, Lei, Huang, Jane, Novotny, William, Kim, Pil, Yu, Yiling, Wu, Binghao, Zhu, Jun
Publicado 2022

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

por Tam, Constantine S., Dimopoulos, Meletios, Garcia-Sanz, Ramon, Trotman, Judith, Opat, Stephen, Roberts, Andrew W., Owen, Roger, Song, Yuqin, Xu, Wei, Zhu, Jun, Li, Jianyong, Qiu, Lugui, D’Sa, Shirley, Jurczak, Wojciech, Cull, Gavin, Marlton, Paula, Gottlieb, David, Munoz, Javier, Phillips, Tycel, Du, Chenmu, Ji, Meng, Zhou, Lei, Guo, Haiyi, Zhu, Hongjie, Chan, Wai Y., Cohen, Aileen, Novotny, William, Huang, Jane, Tedeschi, Alessandra
Publicado 2022

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

por Bachy, Emmanuel, Savage, Kerry J., Huang, Huiqiang, Kwong, Yok-Lam, Gritti, Giuseppe, Zhang, Qingyuan, Liberati, Anna Marina, Cao, Junning, Yang, Haiyan, Hao, Siguo, Hu, Jianda, Zhou, Keshu, Petrini, Mario, Russo, Filomena, Zhang, Huilai, Sang, Wei, Ji, Jie, Ferreri, Andrés José María, Damaj, Gandhi Laurent, Liu, Hui, Zhang, Wei, Ke, Xiaoyan, Ghiggi, Chiara, Huang, Sha, Li, Xiaotong, Yao, Hui, Paik, Jason, Novotny, William, Zhou, Wenxiao, Zhu, Hongjie, Zinzani, Pier Luigi
Publicado 2023

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

por Razavi, Pedram, Li, Bob T., Brown, David N., Jung, Byoungsok, Hubbell, Earl, Shen, Ronglai, Abida, Wassim, Juluru, Krishna, De Bruijn, Ino, Hou, Chenlu, Venn, Oliver, Lim, Raymond, Anand, Aseem, Maddala, Tara, Gnerre, Sante, Satya, Ravi Vijaya, Liu, Qinwen, Shen, Ling, Eattock, Nicholas, Yue, Jeanne, Blocker, Alexander W., Lee, Mark, Sehnert, Amy, Xu, Hui, Hall, Megan P., Santiago-Zayas, Angie, Novotny, William F., Isbell, James M., Rusch, Valerie W., Plitas, George, Heerdt, Alexandra S., Ladanyi, Marc, Hyman, David M., Jones, David R., Morrow, Monica, Riely, Gregory J., Scher, Howard I., Rudin, Charles M., Robson, Mark E., Diaz, Luis A., Solit, David B., Aravanis, Alexander M., Reis-Filho, Jorge S.
Publicado 2019